Published in Virchows Arch on March 22, 2011
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst (2005) 9.10
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol (2003) 8.17
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J (1997) 5.70
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J (1996) 4.26
Changes in the bronchial epithelium in relation to smoking and cancer of the lung; a report of progress. N Engl J Med (1957) 3.29
Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst (1997) 2.83
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer (2001) 2.76
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res (1993) 2.14
Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem (2004) 2.08
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem (1996) 1.88
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene (1999) 1.83
Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol (2002) 1.83
Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst (1995) 1.83
Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect (1995) 1.64
Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. Clin Cancer Res (2002) 1.61
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J (2002) 1.57
The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res (2004) 1.46
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer (2003) 1.43
Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41
Epidermal growth factor receptors in lung tumours. J Pathol (1987) 1.36
c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol (1994) 1.34
Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res (1999) 1.32
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res (2004) 1.32
K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res (1994) 1.28
Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res (2003) 1.15
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res (2001) 1.14
Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res (1997) 1.12
Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg (1999) 1.09
Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J Natl Cancer Inst (1987) 1.08
Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA (1995) 1.07
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res (2002) 1.04
Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients. Oncol Res (2003) 1.02
Signal events: Cell signal transduction and its inhibition in cancer. Oncologist (2003) 1.00
Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest (1993) 0.97
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res (1996) 0.97
Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas. J Thorac Cardiovasc Surg (1994) 0.96
How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis (1999) 0.95
Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. Surg Oncol (1994) 0.95
HER2/neu expression in malignant lung tumors. Semin Oncol (2002) 0.94
Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol (1994) 0.94
p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res (1998) 0.93
Advances in the biology of lung cancer chemoprevention. J Clin Oncol (2005) 0.92
Chemoprevention of lung cancer--from biology to clinical reality. Ann Oncol (2004) 0.92
Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. Eur Respir J (2003) 0.88
Oncogenes and antioncogenes in lung tumorigenesis. Chest (1996) 0.88
Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer (1997) 0.87
Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: a preliminary study. Histopathology (2004) 0.87
Molecularly targeted approaches to the chemoprevention of lung cancer. Clin Cancer Res (2004) 0.86
Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Giles F. Filley Lecture. Chest (1996) 0.84
Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res (2003) 0.84
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer. Ann Thorac Surg (2001) 0.83
Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J (2000) 0.82
A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers. Br J Cancer (1997) 0.80
Chemoprevention strategies for patients with lung cancer in the context of screening. Clin Lung Cancer (2005) 0.80
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers. Chest (2003) 0.79
Pathology of lung cancer. J Thorac Imaging (2000) 0.76
EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions. Anticancer Res (2006) 0.76
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention. Clin Lung Cancer (2003) 0.76
Does c-erbB-2 play a role in the first steps of lung carcinogenesis? Anticancer Res (2005) 0.76
Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med (2012) 2.98
Human cytomegalovirus UL38 protein blocks apoptosis. J Virol (2007) 1.55
Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis. J Infect Dis (2005) 1.54
Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test. Arch Pathol Lab Med (2012) 1.53
Acute mitral regurgitation due to ruptured ePTFE neo-chordae. J Heart Valve Dis (2007) 1.43
Factor structure of the Rutter Teacher Questionnaire in Portuguese children. Rev Bras Psiquiatr (2008) 1.41
Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res (2010) 1.30
Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res (2010) 1.20
Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysis. Hum Pathol (2004) 0.99
EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead. Transgenic Res (2013) 0.97
Genomic analysis of two novel human enterovirus C genotypes found in respiratory samples from Peru. J Gen Virol (2012) 0.94
Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J Proteome Res (2011) 0.93
Population-based active surveillance cohort studies for influenza: lessons from Peru. Bull World Health Organ (2012) 0.93
The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer (2008) 0.92
Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells (2010) 0.92
Andes hantavirus variant in rodents, southern Amazon Basin, Peru. Emerg Infect Dis (2014) 0.91
[The IASLC lung cancer staging project. Comparing the current 6(th) TNM edition with the proposed 7(th) edition]. Rev Port Pneumol (2009) 0.91
In vitro scavenging capacity of annatto seed extracts against reactive oxygen and nitrogen species. Food Chem (2011) 0.88
Autogenous tooth transplantation: evaluation of pulp tissue regeneration. Med Oral Patol Oral Cir Bucal (2011) 0.85
Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours? Virchows Arch (2010) 0.85
Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovasc Toxicol (2009) 0.85
Nickel induces oxidative burst, NF-κB activation and interleukin-8 production in human neutrophils. J Biol Inorg Chem (2010) 0.84
Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci (2005) 0.84
A recombinant antigen recognized by Fasciola hepatica-infected hosts. J Parasitol (2004) 0.84
Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncol (2005) 0.83
Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung. Hum Pathol (2011) 0.82
[Epithelioid hemangioendothelioma of the pleura - A rare presentation of a clinical case]. Rev Port Pneumol (2010) 0.81
Monoclonal anti-CD8 therapy induces disease amelioration in the K/BxN mouse model of spontaneous chronic polyarthritis. Arthritis Rheum (2010) 0.81
Urine antigen detection for the diagnosis of human neurocysticercosis. Am J Trop Med Hyg (2009) 0.81
Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening. Eur J Med Chem (2012) 0.80
Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine. Redox Rep (2010) 0.80
Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs. Redox Rep (2008) 0.80
Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice. Biochim Biophys Acta (2013) 0.80
The BDI-II factor structure in pregnancy and postpartum: Two or three factors? Eur Psychiatry (2008) 0.80
Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk Lymphoma (2008) 0.80
Production and characterization of a monoclonal antibody to Francisella tularensis lipopolysaccharide. Hybridoma (Larchmt) (2007) 0.79
Affective state dependence and relative trait stability of perfectionism in sleep disturbances. Rev Bras Psiquiatr (2011) 0.79
[Glomic tumor: presentation of an infrequent case]. Rev Port Pneumol (2006) 0.79
Evaluation of dentin formed in autogenous tooth transplantation in the dog: a comparison between one- and two-stage surgical techniques. Dent Traumatol (2011) 0.79
Perfectionism and eating attitudes in Portuguese students: a longitudinal study. Eur Eat Disord Rev (2009) 0.78
2-Bromo-5-hydroxyphenylporphyrins for photodynamic therapy: photosensitization efficiency, subcellular localization and in vivo studies. Photodiagnosis Photodyn Ther (2012) 0.78
Antioxidant activity of unexplored indole derivatives: synthesis and screening. Eur J Med Chem (2010) 0.78
[Benign metastasizing leiomyomas]. Acta Med Port (2003) 0.77
RNAi-based GM plants: food for thought for risk assessors. Plant Biotechnol J (2014) 0.77
β-Galactofuranose-containing structures present in the cell wall of the saprophytic fungus Cladosporium (Hormoconis) resinae. Res Microbiol (2010) 0.77
The dependence of α-tocopheroxyl radical reduction by hydroxy-2,3-diarylxanthones on structure and micro-environment. Org Biomol Chem (2012) 0.77
Isolation and identification of antioxidants from Pedilanthus tithymaloides. J Nat Med (2007) 0.77
CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer. Rev Port Pneumol (2010) 0.77
[Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation]. Acta Med Port (2010) 0.77
Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung. BMJ Case Rep (2013) 0.77
The intriguing co-existence of a chronic periaortitis, a pericarditis and a pancreatitis: case report. Acta Reumatol Port (2011) 0.77
2,3-diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure-activity relationship study. Bioorg Med Chem (2010) 0.77
Perfectionism in obsessive-compulsive and eating disorders. Rev Bras Psiquiatr (2009) 0.76
Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system. Med Oncol (2011) 0.76
Development and evaluation of a novel topical treatment for acne with azelaic acid-loaded nanoparticles. Microsc Microanal (2013) 0.76
Cultivar variability of iron uptake mechanisms in rice (Oryza sativa L.). Plant Physiol Biochem (2014) 0.76
Late rupture of expanded polytetrafluoroethylene neochordae used for mitral valve repair. J Thorac Cardiovasc Surg (2009) 0.75
[DIP (desquamative interstitial pneumonia): as a tobacco-associated disease -- case report]. Rev Port Pneumol (2004) 0.75
[Interstitial lung diseases of undetermined cause?]. Rev Port Pneumol (2004) 0.75
Evaluation of chitoligosaccharides effect upon probiotic bacteria. Int J Biol Macromol (2011) 0.75
Rosai-Dorfman disease manifesting as a mediastinal mass with calcifications. J Thorac Imaging (2010) 0.75
Pindolol is a potent scavenger of reactive nitrogen species. Life Sci (2005) 0.75
Inhibition of NF-kB activation and cytokines production in THP-1 monocytes by 2-styrylchromones. Med Chem (2015) 0.75
[Swiftly and well . . . but not always]. Rev Port Pneumol (2005) 0.75
[The premedical syndrome: does it exist in Portugal?]. Acta Med Port (2010) 0.75
[Epithelioid haemangioendothelioma of the pleura: 29 months survival]. Rev Port Pneumol (2006) 0.75
[Catastrophic primary antiphospholipid syndrome]. Acta Med Port (2012) 0.75
Screening hybridomas for cell surface antigens by high-throughput homogeneous assay and flow cytometry. Methods Mol Biol (2014) 0.75
[Pulmonary hamartoma]. Acta Med Port (2002) 0.75
Pulmonary veno-occlusive disease: a case report. Rev Port Cardiol (2010) 0.75
[Varicella zoster pneumonia]. Rev Port Pneumol (2010) 0.75
[Lung adenocarcinoma: application of the WHO 1999/2004 classification to the caseload of the Pathologic Anatomy Service at the Hospital of the Coimbra University]. Rev Port Pneumol (2006) 0.75
[Dural sinus thrombosis]. Acta Med Port (2007) 0.75
Polysomy and amplification of chromosome 7 defined for EGFR gene in squamous cell carcinoma of the lung together with exons 19 and 21 wild type. Rev Port Pneumol (2010) 0.75
[Identification and preservation of parathyroid glands in cadaver parts]. Acta Med Port (2013) 0.75
Perfectionism and eating attitudes in Portuguese university students. Eur Eat Disord Rev (2007) 0.75
Structure-activity studies with cytotoxic anthrapyrazoles. Oncol Rep (2006) 0.75
[Mediastinal angiofolicular lymphoid hyperplasia--Castleman's disease--case report]. Rev Port Pneumol (2006) 0.75
[Morphological features of the pulmonary sequestration]. Rev Port Pneumol (2003) 0.75
Identification of parathyroid glands: anatomical study and surgical implications. Surg Radiol Anat (2014) 0.75
[Aortic insufficiency and rheumatoid nodules - a rare occurrence]. Acta Reumatol Port (2010) 0.75
[Pleomorphic adenoma of the trachea. Case report]. Rev Port Pneumol (2006) 0.75
[Congenital cystic adenomatoid malformation of the lung or congenital pulmonary airway malformation]. Rev Port Pneumol (2003) 0.75
[Broncho-pulmonary adenomas]. Rev Port Pneumol (2004) 0.75
[Not Available]. Rev Port Pneumol (2007) 0.75
Surgical treatment of patent ductus arteriosus in neonates. J Cardiothorac Surg (2015) 0.75
[Angiogenesis and cancer: from biopathology to therapy]. Acta Med Port (2004) 0.75